NCT03185481: Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
- State
- Stopped early
- Phase
- Phase 2
- People
- 5 taking part
- Started
- 6 Jul 2017
- Primary completion
- 24 Oct 2017
- Arms
- 1 mg QD to 15 mg QD PF-06649751
- Results
- Posted on the registry
- 14 Jun 2017: Trial registered
- 6 Jul 2017: Trial started
- 25 Oct 2017: Trial terminated
- 12 Apr 2019: Trial results posted